University of California, San Francisco Logo

University of California, San Francisco | About UCSF | Search UCSF | UCSF Medical Center

Home > Treatment > Drugs
Nucleoside/Nucleotide Analogues
Nonnucleoside Reverse Transcriptase Inhibitors
Protease Inhibitors
Fusion Inhibitors
Chemokine Coreceptor Antagonists
Integrase Inhibitors
Pharmacokinetic Enhancers
Related Resources
About ARV Drugs
Summary tables from the DHHS Guideline Tables
What to Start: Initial Combination Regimens for the Antiretroviral-Naive Patient
Recommended, Alternative, and Other Antiretroviral Regimen Options for Treatment-Naive Patients
ARV Components or Regimens Not Recommended as Initial Therapy
ARV Regimens or Components That Should Not Be Offered at Any Time
Adverse Events of ARVs
Dosage Adjustments for ARV-ARV Drug Interactions (Adult Dosing)
Interactions Database
Stanford Resistance Database
Nucleoside/Nucleotide Analogues
Abacavir (Ziagen, ABC)
Didanosine (Videx, ddI)
Emtricitabine (Emtriva, FTC)
Lamivudine (Epivir, 3TC)
Stavudine (Zerit, d4T)
Tenofovir disoproxil fumarate (Viread, TDF)
Tenofovir alafenamide (TAF)
Zalcitabine (Hivid, ddC) Discontinued by manufacturer 12/31/06
Zidovudine (Retrovir, AZT, ZDV)
Nonnucleoside Reverse Transcriptase Inhibitors
Delavirdine (Rescriptor, DLV)
Efavirenz (Sustiva, Stocrin, EFV)
Etravirine (Intelence, TMC 125, ETV)
Nevirapine (Viramune, NVP)
Rilpivirine (Edurant, TMC 278, RPV)
Protease Inhibitors
Amprenavir (Agenerase, APV) Discontinued by manufacturer 10/07
Atazanavir (Reyataz, ATV)
Darunavir (Prezista, DRV, TMC 114)
Fosamprenavir (Lexiva, Telzir, FPV)
Indinavir (Crixivan, IDV)
Lopinavir/Ritonavir (Kaletra, LPV/r)
Nelfinavir (Viracept, NFV)
Ritonavir (Norvir, RTV)
Saquinavir (Invirase, SQV)
Tipranavir (Aptivus, TPV)
Fusion Inhibitors
Enfuvirtide (Fuzeon, ENF, T-20)
Chemokine Coreceptor Antagonists
Maraviroc (Selzentry, Celsentri, MVC)
Integrase Inhibitors
Dolutegravir (Tivicay, DTG)
Elvitegravir (Vitekta, EVG)
Raltegravir (Isentress, RAL)
Pharmacokinetic Enhancers
Cobicistat (Tybost, COBI)